This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents. Top assignees: Reckitt Benckiser Inc., Adams Laboratories, Inc.. Active years: 2002-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2011
Title: Ralph W. Blume: Innovator in Pharmaceutical Formulations
Introduction
Ralph W. Blume, an accomplished inventor based in Fort Worth, Texas, has significantly contributed to the pharmaceutical industry with his innovative work in drug formulations. With a total of six patents to his name, Blume's inventions focus primarily on improving the therapeutic efficacy of medications through modified release techniques.
Latest Patents
Among his notable patents, Blume has developed a sustained release of guaifenesin combination drugs. This invention introduces a novel pharmaceutical formulation that combines guaifenesin with dextromethorphan, utilizing a specific ratio of hydrophilic and water-insoluble polymers. The formulation is designed to provide therapeutically effective bioavailability of guaifenesin for at least twelve hours after dosing, ensuring sustained therapeutic effects in patients.
Another important patent by Blume focuses on a similar sustained release formulation, this time combining guaifenesin with pseudoephedrine. Like his previous invention, this formulation employs a combination of polymers to achieve a sustained release that maintains therapeutic levels of guaifenesin in the bloodstream for an extended period.
Career Highlights
Blume's professional journey includes significant roles at leading companies in the pharmaceutical sector, such as Reckitt Benckiser Inc. and Adams Laboratories, Inc. His experience in these reputable organizations has honed his skills in drug formulation and development, enabling him to innovate and enhance existing product offerings.
Collaborations
During his career, Ralph W. Blume has worked alongside esteemed colleagues such as Robert D. Davis and Donald Jeffrey Keyser. These collaborations have enriched his work and helped foster a collaborative approach to pharmaceutical innovation, further amplifying the impact of his inventions on the industry.
Conclusion
Ralph W. Blume stands out as a visionary inventor whose contributions to sustained release formulations are making a significant impact in the field of pharmaceuticals. His innovative approach to drug delivery continues to enhance the efficacy of treatments available to patients, establishing him as an invaluable asset in the world of medical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
